Emergent BioSolutions' ACAM2000(R), (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication; Public Health Mpox Outbreak Continues Across Africa & Other Regions

Source :: GlobeNewswire. August 29, 2024
Publication Year :: 2024
Abstract: GAITHERSBURG, Md., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application [...]

Subjects :: United States. Food and Drug Administration
Emergent BioSolutions Inc.
Biotechnology industry -- Health aspects
Vaccinia -- Health aspects
Drug approval -- Health aspects
Public health -- Health aspects
Smallpox -- Health aspects
Smallpox vaccine -- Health aspects
Banking, finance and accounting industries
Business
ACAM2000 (Vaccine) -- Health aspects

Tools